Dose-effect relationships of nonsteroidal anti-inflammatory drugs: A literature review

Clinical Therapeutics

Volumn 24, Issue 8, 2002, Pages 1225-1291

  Emery, Paul ^a   Kong, Sheldon X ^b   Ehrich, Elliot W ^b   Watson, Douglas J ^b   Towheed, Tanveer E ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Adverse events; Dose levels; Efficacy; NSAID; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ANTRAFENINE; AZAPROPAZONE; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; ISOXICAM; KETOPROFEN; LORNOXICAM; MECLOFENAMATE SODIUM; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PARACETAMOL; PIROXICAM; PIRPROFEN; RO 15 8081; TENIDAP; TENOXICAM; TIMEGADINE; TOLMETIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; CONSTIPATION; COXITIS; DATA ANALYSIS; DIARRHEA; DIGESTIVE SYSTEM HEMORRHAGE; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DYSPEPSIA; EMBASE; EPIGASTRIC PAIN; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INCIDENCE; KNEE OSTEOARTHRITIS; LIVER TOXICITY; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; NAUSEA; PUBLICATION; QUALITY CONTROL; RANDOMIZATION; REFLINE; REVIEW; RHEUMATOID ARTHRITIS; STANDARDIZATION; URTICARIA; VERTIGO; VOMITING;

EID: 0036676015     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)80033-9     Document Type: Review

References (12)

1. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States
2. The economic impact of the rheumatic diseases in the United States
3. Rheumatoid arthritis: Treat now, not later!
4. The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis
5. Efficacy and safety of meloxicam in patients with rheumatoid arthritis
6. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis
7. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis
8. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology
9. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update
10. Guidelines for monitoring drug therapy in rheumatoid arthritis
11. Publication bias in clinical research
12. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis